Early predictive factors in routine clinical practice for rituximab therapy response in patients with rheumatoid arthritis.
Evgenija MihajloskaAleksandar DimkovskiAleksandra GrozdanovaAna VasilevskaDubravka AntovaZorica NaumovskaAleksandra Kapedanovska NestorovskaZoran SterjevBashkim OsmaniLjubica ShuturkovaPublished in: Reumatologia (2024)
The optimal model for predicting RTX response at 6 months involves the interaction of all clinical factors examined in this study, as revealed by the analysis of multiple variables.